Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 1/20 | 0.43 |
| ▸ | GNB1 | P62873 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | BLM | P54132 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 3/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.43 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CHAT | P28329 | 1/20 | 0.43 |
| ▸ | BLVRB | P30043 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | FTO | Q9C0B1 | 7/20 | 0.40 |
| ▸ | SMAD3 | P84022 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6823049 | 0.91 | RECQL (0.43) | GNG2GNB1RECQLTDP1MEN1 | |
| SCHEMBL202968 | 0.90 | GNG2 (0.43) | GNG2GNB1RECQLTDP1MEN1 | |
| SCHEMBL29831001 | 0.86 | GNG2 (0.40) | GNG2GNB1RECQLTDP1MEN1 | |
| SCHEMBL345532 | 0.86 | GNG2 (0.40) | GNG2GNB1RECQLTDP1MEN1 | |
| SCHEMBL6415591 | 0.83 | MEN1 (0.34) | GNG2GNB1RECQLTDP1MEN1 | |
| SCHEMBL498286 | 0.83 | MEN1 (0.61) | GNG2GNB1RECQLTDP1MEN1 | |
| SCHEMBL29486978 | 0.83 | MEN1 (0.61) | GNG2GNB1RECQLTDP1MEN1 | |
| SCHEMBL7589676 | 0.83 | SMAD3 (0.37) | GNG2GNB1RECQLTDP1MEN1 | |
| SCHEMBL3717351 | 0.82 | SMAD3 (0.45) | GNG2GNB1RECQLTDP1MEN1 | |
| SCHEMBL20526266 | 0.81 | SMAD3 (0.49) | GNG2GNB1RECQLTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779896-B2 | Magnetic-optical composite nanostructure | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2023-10-10 | — | — | US | claimed |
| EP-3514177-B1 | ANTIBODY SPECIFICALLY BINDING TO PD-1 AND FUNCTIONAL FRAGMENT THEREOF | Beijing hanmi pharm co ltd (CN) | 2023-07-26 | — | — | EP | claimed |
| US-20220146431-A1 | REAGENTS AND METHODS FOR DETECTING INFECTIOUS DISEASES | IONICA SCIENCES | 2022-05-12 | — | — | US | claimed |
| EP-3514176-B1 | ANTIBODY SPECIFICALLY BINDING TO IL-17A AND FUNCTIONAL FRAGMENT THEREOF | BEIJING HANMI PHARMACEUTICAL CO LTD (CN) | 2021-12-15 | — | — | EP | claimed |
| EP-2596119-B1 | METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS | ASTELLAS INST FOR REGENERATIVE MEDICINE (US) | 2021-04-28 | — | — | EP | claimed |
| CN-112391347-A | Magneto-optical composite nanostructures, methods of making same, and methods of detecting, separating, or imaging analytes | 高丽大学校产学协力团 | 2021-02-23 | — | — | CN | claimed |
| US-20210046443-A1 | MAGNETIC-OPTICAL COMPOSITE NANOSTRUCTURE | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2021-02-18 | — | — | US | claimed |
| US-20200385790-A1 | HETERODIMERIC CORE-SHELL NANOPARTICLE IN WHICH RAMAN-ACTIVE MOLECULES ARE LOCATED AT A BINDING PORTION OF A NANOPARTICLE HETERODIMER, USE THEREOF, AND METHOD FOR PREPARING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2020-12-10 | — | — | US | claimed |
| EP-2371927-B1 | Fluorescent dye compounds, conjugates and uses thereof | LIFE TECHNOLOGIES CORP (US) | 2020-03-11 | — | — | EP | claimed |
| US-20190256588-A1 | ANTIBODY SPECIFICALLY BINDING TO IL-17A AND FUNCTIONAL FRAGMENT THEREOF | BEIJING HANMI PHARM. CO., LTD. (CN) | 2019-08-22 | — | — | US | claimed |
| US-20060228357-A1 | dimerization and docking domains; fusion proteins | IBC PHARMACEUTICALS, INC. | 2006-10-12 | — | — | US | claimed |
| US-20060063734-A1 | 4,7-dichlorofluorescein dyes as molecular probes | APPLERA CORPORATION (US) | 2006-03-23 | — | — | US | claimed |
| US-20050084870-A1 | 4,7-dichlorofluorescein dyes as molecular probes | APPLERA CORPORATION (US) | 2005-04-21 | — | — | US | claimed |
| US-6504024-B2 | Useful as substrates for polymerase enzymes; used in preparing fluorescently-labeled nucleotides useful as substrates for thermostable polymerases | PE CORPORATION (NY) | 2003-01-07 | — | — | US | claimed |
| EP-0777749-B1 | COUPLED AMPLIFICATION AND LIGATION METHOD | PE CORP NY (US) | 2002-10-30 | — | — | EP | claimed |
| US-20020081616-A1 | 4,7-dichlorofluorescein dyes as molecular probes | THE PERKIN-ELMER CORPORATION | 2002-06-27 | — | — | US | claimed |
| JP-3102800-B2 | — | — | 2000-10-23 | — | — | JP | claimed |
| US-6130073-A | DETECTING A TARGET NUCLEOTIDE SEQUENCES IN A SAMPLE; AMPLIFYING TARGET NUCLEOTIDE SEQUENCES BY PRIMER EXTENSION, LIGATING OLIGONUCLEOTIDE PROBES AND DETECTING LIGATION PRODUCTS | PERKIN-ELMER CORP., APPLIED BIOSYSTEMS DIVISION (US) | 2000-10-10 | — | — | US | claimed |
| US-5912148-A | DETECTION OF POLYNUCLEOTIDE IN SAMPLE BY POLYMERASE CHAIN REACTION AND LIGATION OF OLIGONUCLEOTIDE PROBES WHICH HYBRIDIZE TO AMPLIFICATION PRODUCT, DETECTION OF LIGATION PRODUCT IN ONE REACTION VESSEL | PERKIN-ELMER CORPORATION APPLIED BIOSYSTEMS (US) | 1999-06-15 | — | — | US | claimed |
| WO-1996006190-A2 | COUPLED AMPLIFICATION AND LIGATION METHOD | PERKIN-ELMER CORPORATION (US) | 1996-02-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063734-A1 | 4,7-dichlorofluorescein dyes as molecular probes | SPAG5, SPG11, SPIN4 | GNG2 3691/4885GNB1 3518/4885RECQL 193/4885 |
| US-20050084870-A1 | 4,7-dichlorofluorescein dyes as molecular probes | DCLRE1B, DCTD, DDB1 | GNG2 3164/4885GNB1 2951/4885RECQL 226/4885 |
| US-20020081616-A1 | 4,7-dichlorofluorescein dyes as molecular probes | SPAG5, SPG11, SPIN4 | GNG2 3726/4885GNB1 3582/4885RECQL 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.